LONDON - Phytopharm plc fell victim to the fallout from Pfizer Inc.'s $66 billion acquisition of Pharmacia Corp., as Pfizer dropped development of P57, an obesity treatment based on a plant extract discovered by Phytopharm. (BioWorld International)